News Centogene N.V.

Equities

CNTG

NL0014040206

Delayed Nasdaq Other stock markets 01:26:06 30/04/2024 am IST			5-day change	1st Jan Change
0.46 ^USD	-5.91%		-2.15%	-61.67%

02/04	Centogene Gets Nasdaq Noncompliance Notice	MT
19/03	Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Centogene Gets Nasdaq Noncompliance Notice	03/04	MT
CENTOGENE Receives Nasdaq Non-Compliance Notice	03/04	GL
Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics	19/03	MT
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders	19/03	GL
Centogene N.V. Announces the Extension of an Ongoing Partnership with Takeda to Continue Providing Access to Genetic Testing for Patients with Lysosomal Storage Disorders	19/03	CI
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency	01/03	GL
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing	28/02	GL
CENTOGENE Explores Strategic Alternatives	28/02	GL
Centogene Explores Strategic Alternatives	28/02	CI
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration	25/01	GL
Centogene N.V. and the Laboratory of Human Genetics of Infectious Diseases At Institut Imagine Announce Rare Disease Research Collaboration	25/01	CI
CENTOGENE Receives French Research Tax Credit Accreditation	24/01	GL
Centogene N.V. and The Michael J. Fox Foundation for Parkinson's Research Announces Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics	23/01	CI
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics	23/01	GL
CENTOGENE Announces Preliminary Full Year 2023 Revenue	18/01	GL
Centogene N.V. Provides Earnings Guidance for the Full Year 2023	18/01	CI
Centogene N : Minutes for Centogene EGM December 2023	19/12	PU
CENTOGENE Announces Voting Results of Extraordinary General Meeting	19/12	GL
Centogene N.V. Announces Changes to Supervisory Board	18/12	CI
Centogene N.V.'s Frontotemporal Dementia Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone	13/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Centogene N.V.

Equities

CNTG

NL0014040206

Summary

Filters